Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	1.05B +358.8%
Revenue (ttm)	1.32B +330.6%
Net Income	25.57M +2,924.8%
EPS	1.21 +1,244.4%
Shares Out	19.94M
PE Ratio	43.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,776
Open	54.90
Previous Close	52.67
Day's Range	51.30 - 57.50
52-Week Range	27.94 - 70.16
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In fiscal year 2026, Novelix Pharmaceuticals's revenue was 1.32 billion, an increase of 330.60% compared to the previous year's 307.33 million. Earnings were 25.57 million, an increase of 2924.85%.